RUCAPARIB CAMSYLATE

RUCAPARIB CAMSYLATE

Biochem/physiol Actions

Rucaparib is an inhibitor of the DNA repair enzyme poly-ADP ribose polymerase-1 (PARP-1). It has been found to have anticancer activity in a number of cancers and has been approved for treatment of previously treated, BRCA-mutant ovarian cancer.

Legal Information

Pfizer is a registered trademark of Pfizer, Inc.

Sold for research purposes under agreement from Pfizer Inc.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Manufacturer Solubility Form Assay Price Quantity
3573561 RUCAPARIB CAMSYLATE pale yellow SIGMA-ALDRICH DMSO: 2 mg/mL, clear powder ≥98% (HPLC)
£490.29 (exc VAT) per 25MG
-
+
3573562 RUCAPARIB CAMSYLATE pale yellow SIGMA-ALDRICH DMSO: 2 mg/mL, clear powder ≥98% (HPLC)
£142.07 (exc VAT) per 5MG
-
+